Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIR Medical Informatics

Date Submitted: Sep 24, 2021
Open Peer Review Period: Sep 23, 2021 - Nov 18, 2021
Date Accepted: Mar 14, 2022
(closed for review but you can still tweet)

The final, peer-reviewed published version of this preprint can be found here:

Research and Application of Artificial Intelligence Based on Electronic Health Records of Patients With Cancer: Systematic Review

Yang X, Mu D, Peng H, Li H, Wang Y, Wang P, Wang Y, Han S

Research and Application of Artificial Intelligence Based on Electronic Health Records of Patients With Cancer: Systematic Review

JMIR Med Inform 2022;10(4):e33799

DOI: 10.2196/33799

PMID: 35442195

PMCID: 9069295

Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.

Research and application of artificial intelligence based on electronic health record data from patients with cancer: a systematic review

  • Xinyu Yang; 
  • Dongmei Mu; 
  • Hao Peng; 
  • Hua Li; 
  • Ying Wang; 
  • Ping Wang; 
  • Yue Wang; 
  • Siqi Han

ABSTRACT

Background:

With the accumulation of electronic health records data and the development of artificial intelligence, patients with cancer urgently need new evidence of more personalized clinical and demographic characteristics and more sophisticated treatment and prevention strategies. However, no research has systematically analyzed the application and significance of electronic health records and artificial intelligence in cancer care.

Objective:

In this study, we reviewed the literature on the application of AI based on EHR data from patients with cancer, hoping to provide reference for subsequent researchers, and help accelerate the application of EHR data and AI technology in the field of cancer, so as to help patients get more scientific and accurate treatment.

Methods:

Three databases were systematically searched to retrieve potentially relevant articles published from January 2009 to October 2020. A combination of terms related to "electronic health records", "artificial intelligence" and "cancer" was used to search for these publications.

Results:

Of the 1034 articles considered, 148 met the inclusion criteria. The review has shown that ensemble methods and deep learning were on the rise. It presented the representative literatures on the subfield of cancer diagnosis, treatment and care. In addition, the vast majority of studies in this area were based on private institutional databases, resulting in poor portability of the proposed methodology process.

Conclusions:

The use of new methods and electronic health records data sharing and fusion were recommended for future research. With the help of specialists, artificial intelligence and the mining of massive electronic medical records could provide great opportunities for improving cancer management.


 Citation

Please cite as:

Yang X, Mu D, Peng H, Li H, Wang Y, Wang P, Wang Y, Han S

Research and Application of Artificial Intelligence Based on Electronic Health Records of Patients With Cancer: Systematic Review

JMIR Med Inform 2022;10(4):e33799

DOI: 10.2196/33799

PMID: 35442195

PMCID: 9069295

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.